Valuation (29%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -0.95 | N/A |
PEG Ratio (TTM) | 0.07 | N/A |
P/S Ratio (TTM) | 27.52 | N/A |
P/B Ratio (TTM) | 0.37 | N/A |
P/FCF Ratio (TTM) | -3.59 | N/A |
Price to 5YR AVG Earnings Ratio | -0.78 | N/A |
Price to 5YR AVG FCF Ratio | -2.77 | N/A |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -27.20% | N/A |
ROE (TTM) | -37.24% | N/A |
Net Profit Margin (TTM) | -1,819.53% | N/A |
ROIC 5YR AVG | -19.73% | N/A |
Growth (8%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -503.92% | -386.28% | -226.34% |
Revenue | -38.27% | N/A | 137.08% |
Net Income | -505.40% | -1,708.83% | -1,033.07% |
Cash Flow | -9.94% | -797.15% | -479.99% |
Health (21%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 0.47 | N/A |
Quick Ratio (TTM) | 0.43 | N/A |
D/E Ratio (TTM) | 0.01 | N/A |
Interest Coverage (TTM) | -12.26 | N/A |
Piotroski F-Score | 2 | N/A |
Altman Z-Score | N/A | N/A |
LTL to 5YR AVG FCF | -0.07 | N/A |
Shares Outstanding Growth 5YR AVG | 13,727.58% | N/A |